Therapiemanagement-Anwendung für Hämophilie-Patienten besteht erfolgreich die Rezertifizierung nach EuroPriSe.
When looking forward to the new year 2021, we are very confident that we will soon make further progress with regard to the approval of our certification program and our accreditation as a certification body for this program.
Therapy management application for haemophilia patients successfully passes recertification according to EuroPriSe